FindTrial
Sign In

pILOT STUDY TO EVALUATE QUALITY OF LIFE, SEIZURES CONTROL AND SIDE EFFECTS IN PATIENTS WITH BRAIN TUMORS AND EPILEPSY TREATED WITH LEVETIRACETAM IN MONOTHERAPY

pILOT STUDY TO EVALUATE QUALITY OF LIFE, SEIZURES CONTROL AND SIDE EFFECTS IN PATIENTS WITH BRAIN TUMORS AND EPILEPSY TREATED WITH LEVETIRACETAM IN MONOTHERAPY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-004146-40-IT
Enrollment
Unknown
Registered
2007-03-22
Start date
2005-03-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREATMENT OF EPILEPSY IN PATIENTS WITH BRAIN TUMORS MedDRA version: 9.1 Level: LLT Classification code 10015037 Term: Epilepsy

Interventions

Trade Name: KEPPRA 60CPR RIV 500MG Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Levetiracetam Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 500-

Sponsors

ISTITUTI FISIOTERAPICI OSPITALIERI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026